CK-MB

Global Cardiac Marker Testing Market Expected to Reach $6.9 Billion by 2028, Driven by Aging Population and Rising Cardiovascular Diseases - ResearchAndMarkets.com

Retrieved on: 
星期四, 十一月 9, 2023
Research, Medical Devices, Medical Supplies, Seniors, Cardiology, Biotechnology, Consumer, Health, Science, Other Science, BNP, Prevalence, Troponin I, Clinical Laboratory Improvement Amendments, ASP, Cardiovascular disease, CK-MB, USD, Point-of-care testing, Membrane protein, Compound annual growth rate, Diagnosis, Growth, Reagent, CHF, Government agency, Troponin, ELISA, Medical device, Atherosclerosis, Disease, Myoglobin, Chemiluminescence

The global cardiac marker testing market is poised for substantial growth, with projections estimating it to reach USD 6.9 billion by 2028, a significant increase from its 2022 value of USD 4.1 billion.

Key Points: 
  • The global cardiac marker testing market is poised for substantial growth, with projections estimating it to reach USD 6.9 billion by 2028, a significant increase from its 2022 value of USD 4.1 billion.
  • Aging Population: The increasing global aging population has led to a higher prevalence of cardiovascular diseases.
  • Rising Cardiovascular Diseases: Cardiovascular diseases are on the rise worldwide, making cardiac marker testing an essential tool for the diagnosis and monitoring of these conditions.
  • In 2022, laboratory testing facilities represented the largest share, accounting for 61.2% of the global cardiac marker testing market.

Cardiac Marker Testing Market by Product, Component, Disease, End-user and Region - Global Forecast to 2027 - ResearchAndMarkets.com

Retrieved on: 
星期一, 十一月 7, 2022
Health, Cardiology, Natriuresis, POCT, Government, Growth, Investment, Natriuretic peptide, CAGR, Component, Membrane protein, CK-MB, POC, Biomarker, Troponin I, Reagent, BNP, Myoglobin, Heart failure, USD, Lab, Myocardial infarction, Medical device, Disease

The global cardiac marker testing market is projected to reach USD 7.7 Billion by 2027 from USD 5.0 Billion in 2022, at a CAGR of 8.7% during the forecast period.

Key Points: 
  • The global cardiac marker testing market is projected to reach USD 7.7 Billion by 2027 from USD 5.0 Billion in 2022, at a CAGR of 8.7% during the forecast period.
  • Troponin I and T estimated held the largest share of cardiac marker testing market in 2021, by Biomarker Type
    Based on biomarker type, the cardiac marker testing market is segmented into Troponin I and T, Creatine Kinase-MB (CK-MB), Natriuretic Peptide (BNP and Nt-proBNP), Myoglobin, High-sensitivity C-reactive Protein (hs-CRP), and other cardiac biomarkers.
  • The Troponin I and T segment accounted for the largest share of 51.1 % of the cardiac marker testing market in 2021.
  • In 2021, the laboratory testing facilities segment accounted for the largest share of 61.4% of the global cardiac marker testing market.

Global Cardiac Marker Analyzer Market to 2027 - Impact Analysis of COVID-19 - ResearchAndMarkets.com

Retrieved on: 
星期三, 二月 23, 2022
Health, Cardiology, Physician, Death, Growth, Heart, CK-MB, Collection, Worldometer, COVID-19, Acute coronary syndrome, ACS, IMA, BNP Paribas, Infarction, Degenerative disease, Patient, Myoglobin, CVD, Research, Troponin I, Pharmaceutical industry

The prevention of cardiac diseases by monitoring the heart conditions via cardiac biomarker testing is the profound approach for obtaining rapid results for immediate diagnosing and treatment.

Key Points: 
  • The prevention of cardiac diseases by monitoring the heart conditions via cardiac biomarker testing is the profound approach for obtaining rapid results for immediate diagnosing and treatment.
  • Cardiac biomarkers are used as risk stratification for various cardiovascular diseases (CVDs), which include myocardial infraction, congestive heart failure, acute coronary syndrome (ACS) among others.
  • The COVID-19 pandemic has restricted the growth of the Cardiac Marker Analyzer market, by social restrictions and other precautionary measures taken in response to the COVID-19 pandemic.
  • In the years to come, physicians are likely to witness an increase in influx of patients, hence driving the cardiac marker analyzer market.

Worldwide Heart Attack Diagnostics Industry to 2026 - Technological Advancements are Driving Growth - ResearchAndMarkets.com

Retrieved on: 
星期五, 十一月 5, 2021
Health, Cardiology, Population, Degenerative disease, ECG, USD, American Heart Association, Troponin, CDC, Blood, Growth, Hospital, Troponin T, CK-MB, Tobacco, Death, Medical device

For example, India and China witness millions of deaths every year due to cardiovascular diseases.

Key Points: 
  • For example, India and China witness millions of deaths every year due to cardiovascular diseases.
  • Thus, North America is expected to dominate the overall heart attack diagnostics market over the forecast period (2021 - 2026).
  • While in Canada, deaths due to heart attack and cardiovascular diseases are as low as 189 out of 100,000 (2019), out of which the heart attack deaths are very less.
  • Whereas, in the other part of North America, i.e., Mexico, the death rate due to heart attack and cardiovascular diseases are quite high.